File Name,Company Name
Zehna Corporate Deck SymBiosis,"Avapro
Cozaar

Indication

Company"
PS_TCRR_NOTE_1.5.23,"TCR2 Therapeutics, Inc"
Grace Sciece Platform (9.2.20),Grace Science
AcuamarkDx Series A_Corp Deck,ResearchDx
coding.bio_deck,"Negotiation

5

Collaboration

1"
Centurion_BioPharma-Non-Confidential_2021_2,Centurion BioPharma Corporation
JPM_SRZN_NOTE_11.28.22,JPM SE
G_ACET_IOC_4.8.21,ACET
C_ARQT_NOTE_11.15.22,LLC
B_RXRX_IOC_9.21.21,RXRX
Dianomi Non-Confidential Slides - v3,Dianomi Therapeutics
KBC_MAAT.FR_IOC_12.14.21,KBC Securities NV
Engrail Therapeutics,Darigabat
WB_VOR_IOC_1.25.22,VOR33
E_FNCH_IOC_8.10.21,Livescault
CG_GRNA_IOC_12.8.22,Canaccord Genuity
LT_AVXL_NOTE_6.22.21,"Windtree Therapeutics, Inc"
LT_PHGE_IOC_4.15.21,BiomX Inc
Graviton Corporate Presentation July 2022,Graviton Holding Company
Bectas Tx Non-Con - Aug.1.2022,Bectas Therapeutics
20 080822_PRTA_Research Summary,"Overview 
Corporate Summary"
CT one-pager Dec 22,circadiantherapeutics
221003_PRE_Numab Non-Confidential Presentation,Investment Thesis
2022-3-18 Apeximmune non-confidential Baird,"Innovative Therapeutics for 
Cancer Immunotherapy"
Alto Overview_April 2022,"ALTO-300

MDD

PTSD

MDD

PTSD"
[NON-NDA] Integral Overview,"Disclaimer

Integral"
JMP_NXTC_IOC_5.26.20,NextCure
Flare Non-Con Deck November 2022,Covalency
AscelpiX Corporate Presentation NON CONFIDENTIAL Feb 8 2022,Growing nAMD Market Opportunity
